ArticlePharmacoEconomics1992
A review of limited lists and formularies: are they cost-effective?
Article in PharmacoEconomics, 1992. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pharmacists' considerations on non-medical switching at the hospital: a systematic review of the economic outcomes of cost-saving therapeutic drug classes.European journal of hospital pharmacy : science and practice · 2021Pooled it
- Personal Formularies of Primary Care Physicians Across 4 Health Care Systems.JAMA network open · 2021Article
- Impact of removal and restriction of me-too medicines in a hospital drug formulary on in- and outpatient drug prescriptions: interrupted time series design with comparison group.Implementation science : IS · 2019Article
- Drug selection in French university hospitals: analysis of formularies for nine competitive pharmacological classes.British journal of clinical pharmacology · 2011Article
- Factors influencing GPs' choice between drugs in a therapeutic drug group. A qualitative study.Scandinavian journal of primary health care · 2007Article
- Prescribing at the interface between primary and secondary care in the UK. Towards joint formularies?PharmacoEconomics · 1999Article
- Constraints on antidepressant prescribing and principles of cost-effective antidepressant use. Part 1: Depression and its treatment.PharmacoEconomics · 1997Review
- The role of pharmacoeconomics in disease management. A pharmaceutical benefit management company perspective.PharmacoEconomics · 1996Article
- A UK national prescribing list?PharmacoEconomics · 1995Article
- The formulary decision-making process in a health maintenance organisation setting.PharmacoEconomics · 1994Article
- High technology drugs for cancer: the decision process for adding to a formulary.PharmacoEconomics · 1993Article
- Economic impact of cost-containment strategies in third party programmes in the US. Part II.PharmacoEconomics · 1993Review
- Drug utilisation review and pharmacoeconomics: interaction after parallel development?PharmacoEconomics · 1993Review
- Determinants of hospital drug expenditures in Western Europe.PharmacoEconomics · 1993Article
- The formulary decision-making process in a US academic medical centre.PharmacoEconomics · 1993Article
- Economic constraints and prescribing patterns in New Zealand.PharmacoEconomics · 1992Article
- Institutional formularies: the relevance of pharmacoeconomic analysis to formulary decisions.PharmacoEconomics · 1992Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The 'limited list' or 'formulary' concept has been used to promote rational use of drugs and to set standards for drug use. Recently the concept has been aimed more toward containment of drug costs. Effective hospital formulary systems assist in purchasing and inventory management. Application of the formulary concept has resulted in savings within specific classes of drugs and in total hospital drug costs. Key features which promote effectiveness are development of policies by prescriber consensus and continued education along with feedback on drug usage. The formulary concept also provides a foundation for appropriate use of drugs in hospitals. In the community setting, limited lists can achieve cost savings and can assist in the rational use of drugs. National limited lists have been less successful in controlling overall drug costs, probably because they have focused on economic effects, rather than education, feedback or user participation. Properly organised drug rationalisation policies embracing the limited list concept can improve health outcomes by promoting rational drug use. They can also contain or reduce drug costs.
Indexed as
Identifiers
10147029What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.